Clinical trials
Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials
Below are recruiting gastric or gastroesophageal junction adenocarcinoma clinical trials, each written for real people, not researchers. We’re tracking 961 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07770100RecruitingPhase 2
Matching immunotherapy and targeted radiation for advanced cancer
This trial tests combining immunotherapy (a treatment that boosts your immune system to fight cancer) with a targeted type of radiation called SBRT, which precisely delivers high-dose radiation to multiple cancer spots. The main goal is to see if this combination helps control metastatic cancer (cancer that has spread) better than standard care.
Lexington, KentuckyAges 18–99 - NCT07561840Recruiting
Exercise Training After Stomach or Esophagus Cancer Surgery
This study tests whether a guided exercise program helps people recover better after surgery for esophageal or gastric (stomach) cancer. Researchers will track your strength, fitness, and quality of life over time.
Hirakata, OsakaAges 18 years+ - NCT07872683Recruiting
Drinking carbohydrates before hip or leg surgery: maltodextrin vs sugar water
This study compares two drinks given before surgery—maltodextrin (a carbohydrate powder mixed with water) versus sugar water—to see which one keeps the stomach empty and reduces risks during surgery on the lower limbs. It may help older patients have a safer and more comfortable experience.
Denpasar, BaliAges 60 years+ - NCT07791849Recruiting
Comparing two stomach protectors after stem cell transplant
This study compares two medications, GMPA and PPI, that protect the stomach during a stem cell transplant. It aims to see which one is better at preventing stomach problems and reducing the risk of a complication called graft-versus-host disease (aGVHD), where donor cells attack the patient's body.
HangzhouAges 12–70 - NCT07795645Recruiting
AI model training for stomach, heart, and brain diseases
This study is testing an artificial intelligence (AI) system that learns from your medical records to better understand and possibly help with diseases like stomach issues, heart problems, and strokes. It may improve how doctors use information from your visit to guide your care.
BeijingAges 18 years+ - NCT07796503Recruiting
Comparing two ways to measure the bypass in weight-loss surgery
This study compares two methods for choosing the length of the intestinal bypass in a weight-loss surgery called one-anastomosis gastric bypass. It may help improve weight loss and reduce complications.
AlmatyAges 18–65 - NCT07700420RecruitingPhase 1
Chemo and personalized radiation for esophageal cancer before and after surgery
This trial tests combining chemotherapy (FLOT) with a new type of personalized radiation (PULSAR) before and after surgery for esophageal cancer. It aims to see if this approach is safe and effective.
Dallas, TexasAges 18 years+ - NCT07808164Recruiting
Protein markers in solid tumors: a Vietnamese tissue study
This study looks at tissue samples from Vietnamese patients with solid tumors to understand the presence of certain proteins (ENPP1, cGAS, and FAP). The goal is to learn more about these tumors, which might help develop better treatments in the future.
Hanoi, HanoiAges 18 years+ - NCT07816263Recruiting
Guaraná supplement for cancer-related fatigue
This trial tests whether a natural supplement called guaraná can help reduce fatigue in people undergoing cancer treatment. Guaraná contains caffeine and other compounds that may boost energy and improve well-being.
Bogotá, Bogota D.C.Ages 18 years+ - NCT07809425Recruiting
Pain relief options for gastric bypass surgery
This study compares two ways to manage pain after gastric bypass surgery: a nerve block alone versus a nerve block plus a lidocaine drip. The goal is to see which approach provides better pain relief and fewer side effects.
AlexandriaAges 18–60 - NCT07532902RecruitingPhase 1
BMS-986504 with standard treatment for advanced solid tumors
This trial tests a new drug called BMS-986504 alongside standard treatments for certain advanced cancers (mesothelioma, stomach/esophageal cancer, or bladder cancer). The drug targets a specific genetic change (MTAP deletion) that may make cancer cells more vulnerable to treatment. Joining could help you access a new therapy, but it may not be suitable for everyone.
Basking Ridge, New JerseyAges 18 years+ - NCT07705334RecruitingPhase 1
Study of SHY-ONC6 for advanced solid tumors
This trial tests a new drug called SHY-ONC6 that targets and breaks down cancer cells. It's for people with advanced solid tumors that haven't responded to standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT07638410Recruiting
Getting fit before major cancer surgery
This trial tests whether special preparation exercises and wellness support before chemotherapy and major abdominal or pelvic surgery can help you recover better and stay stronger. You'll work with a team including exercise specialists and mental health counselors before your operation.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07814027Recruiting
Trial comparing two surgeries for achalasia
This trial compares two surgeries to treat achalasia, a condition where the esophagus fails to push food into the stomach. Both procedures aim to relax the muscle at the bottom of the esophagus, and the study will see which one works better for improving your symptoms.
Minya, Minya GovernorateAges 18–75 - NCT07809620Recruiting
Acid reflux surgery: Who is likely to feel better?
This study looks at patients who are planning to have surgery for severe acid reflux (called fundoplication). It aims to find out which patients are most likely to see their symptoms improve after the operation, so doctors can better choose who will benefit.
Minya, Minya GovernorateAges 18 years+ - NCT07583810RecruitingPhase 2
Nemtabrutinib and Rituximab for Marginal Zone Lymphoma
This trial tests a combination of two drugs—nemtabrutinib (a BTK inhibitor that targets cancer cells) and rituximab (an antibody drug)—to treat marginal zone lymphoma, a type of blood cancer. The study aims to see if this combination works better than standard treatments.
Duarte, CaliforniaAges 18 years+ - NCT07814248RecruitingPhase 1
TS-104 for advanced solid tumors
This trial tests a new drug called TS-104 for people with certain advanced solid tumors that have stopped responding to standard treatments. The drug is given alone (not with other cancer treatments) to see if it can shrink tumors or slow their growth.
Maumee, OhioAges 18 years+ - NCT07714980Recruiting
Acupoint stimulation timing for stomach cancer surgery recovery
This trial tests whether giving a gentle, needle-free acupoint stimulation before or after stomach cancer surgery helps speed up recovery. The stimulation uses a small device on the skin, similar to a tens unit, to support recovery after laparoscopic gastrectomy.
Dongying, ShandongAges 18–80 - NCT07646574Enrolling by invitation
Non-surgical treatment after immunotherapy for specific gastric cancer
This trial tests whether patients with advanced gastric cancer (a specific type called dMMR/MSI-H) can be treated without surgery after receiving immunotherapy and chemotherapy. The goal is to see if this approach can control the cancer while avoiding the risks of surgery.
Chengdu, SichuanAges 18 years+ - NCT07474324RecruitingPhase 2
Targeted therapy plus chemo vs chemo alone for stage 3 stomach cancer
This trial tests adding disitamab vedotin (a drug that targets HER2) to standard chemotherapy (SOX) after surgery for stage 3 stomach cancer. The goal is to see if the combination works better than chemo alone to prevent cancer from coming back.
Nanjing, JiangsuAges 18–75 - NCT07639853Enrolling by invitation
Doctor feedback survey on Concerto Versa coils
This study gathers feedback from doctors who use Concerto Versa detachable coils (small metal devices that help treat brain aneurysms). The survey helps improve how these coils work and are used.
New York, New YorkAges 22 years+ - NCT07583927Enrolling by invitation
Blood Flow Monitoring During Stomach Cancer Surgery
This study examines how blood flow changes in tiny vessels under the tongue during a specific type of fluid management strategy in patients undergoing stomach cancer surgery. Researchers hope this information may help improve surgical outcomes and patient safety.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07521332RecruitingPhase 4
Testing Apixaban to Prevent Bleeding Complications in Cirrhosis
This study tests whether a blood thinner called apixaban can safely prevent dangerous bleeding in people with cirrhosis (liver scarring) who have portal hypertension (high blood pressure in veins leading to the liver). The goal is to see if it reduces bleeding risk without causing excessive bleeding.
Hyderābād, SindhAges 18 years+ - NCT07504913Recruiting
Quality of life survey for stomach cancer patients after surgery
This study tests a new questionnaire to measure quality of life in people who had surgery to remove stomach cancer. If you had surgery for stomach cancer between 1 month and 5 years ago and are cancer-free now, your answers can help improve care.
Badalona, BarcelonaAges 18 years+
Hear when a new Gastric or Gastroesophageal Junction Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric or gastroesophageal junction adenocarcinoma?
- Yes. Clin2 currently lists 961 recruiting gastric or gastroesophageal junction adenocarcinoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric or gastroesophageal junction adenocarcinoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric or gastroesophageal junction adenocarcinoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Gastric / Gastroesophageal Junction Adenocarcinoma
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma
- Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Advanced Gastroesophageal Junction Adenocarcinoma
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.